CorMedix (CRMD) Tax Provisions (2011 - 2025)
CorMedix (CRMD) reported Tax Provisions of $68.2 million for Q4 2025, up 29662402.17% on a YoY basis from N/an in Q4 2024, and up 221.86% sequentially from -$56.0 million in Q3 2025.
CorMedix (CRMD) Tax Provisions (2011 - 2025) Analysis & Trends
CorMedix (CRMD) has 9 years of Tax Provisions data on file, last reported at $68.2 million in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions rose 29662402.17% year-over-year to $68.2 million; the trailing twelve-month figure through Dec 2025 stood at $12.8 million (up 1014.54% YoY), and the FY2025 full-year result was $12.8 million, up 1014.55% from the prior year.
- Tax Provisions grew to $68.2 million in Q4 2025, from -$56.0 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $68.2 million in Q4 2025 to a low of -$56.0 million in Q3 2025.
- A 4-year average of $1.1 million and a median of -$2730.0 in 2024 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 29662402.17% in 2025, while the deepest fall reached 1070593.35% in 2025.
- Tracing CRMD's Tax Provisions over 4 years: stood at $1.9 million in 2021, then slumped by 131.21% to -$585617.0 in 2022, then jumped by 99.96% to -$230.0 in 2024, then jumped by 29662402.17% to $68.2 million in 2025.
- Business Quant data shows CRMD's Tax Provisions at $68.2 million in Q4 2025, -$56.0 million in Q3 2025, and $521507.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | 68.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 68.22 Mn |
| Sep 30, 2025 | -55.99 Mn |
| Jun 30, 2025 | 521,507.00 |
| Dec 31, 2024 | -230.00 |
| Sep 30, 2024 | 5,230.00 |
| Jun 30, 2024 | -5,230.00 |
| Mar 31, 2024 | -1.39 Mn |
| Jun 30, 2022 | -585,617.00 |
| Dec 31, 2021 | 1.88 Mn |
| Jun 30, 2021 | -1.25 Mn |
| Dec 31, 2020 | 6.51 Mn |
| Jun 30, 2020 | -5.17 Mn |
| Dec 31, 2019 | 11.08 Mn |
| Jun 30, 2019 | -5.06 Mn |
| Dec 31, 2016 | 2.00 |
| Sep 30, 2016 | 7.00 |
| Jun 30, 2016 | 3.00 |
| Mar 31, 2016 | -31.00 |
| Dec 31, 2015 | 38.00 |
| Sep 30, 2015 | -7.00 |